Heparan sulfate is required for bone morphogenetic protein-7 signaling

被引:106
作者
Irie, A [1 ]
Habuchi, H
Kimata, K
Sanai, Y
机构
[1] Tokyo Metropolitan Inst Med Sci, Dept Biochem Cell Res, Bunkyo Ku, Tokyo 1138613, Japan
[2] Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan
关键词
bone morphogenetic protein; glycosaminoglycan; heparan sulfate; proteoglycan;
D O I
10.1016/S0006-291X(03)01500-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although genetic studies have suggested that heparan sulfate (HS) is involved in bone morphogenetic protein (BMP)-mediated embryonic morphogenesis, it is unclear whether HS is directly involved in BMP-mediated signaling. Here, we investigate the involvement of HS in BMP-7 signaling. We show that HS and heparin chains specifically bind to BMP-7. Digestion of cell-surface HS with heparitinase interferes with BMP-7-mediated Smad phosphorylation in ROS 17/2.8 osteoblastic cells. Inhibiting sulfation of cell-surface HS with chlorate also causes interruption of Smad phosphorylation. Addition of exogenous heparin to ROS 17/2.8 cells prevents BMP-7-mediated Smad phosphorylation rather than enhances the BMP-7 signal, suggesting that HS should be anchored on the plasma membrane for BMP signaling. Moreover, BMP-7 binding to ROS 17/2.8 cells is inhibited by chlorate treatment and exogenous application of heparin. These results demonstrate that BMP-7 specifically binds to cell-surface HS and the BMP-7-HS interaction is required for BMP-7 signaling. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:858 / 865
页数:8
相关论文
共 43 条
[1]   Signalling by glial cell line-derived neurotrophic factor (GDNF) requires heparan sulphate glycosaminoglycan [J].
Barnett, MW ;
Fisher, CE ;
Perona-Wright, G ;
Davies, JA .
JOURNAL OF CELL SCIENCE, 2002, 115 (23) :4495-4503
[2]   Tout-velu is a Drosophila homologue of the putative tumour suppressor EXT-1 and is needed for Hh diffusion [J].
Bellaiche, Y ;
The, I ;
Perrimon, N .
NATURE, 1998, 394 (6688) :85-88
[3]   Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase [J].
Bullock, SL ;
Fletcher, JM ;
Beddington, RSP ;
Wilson, VA .
GENES & DEVELOPMENT, 1998, 12 (12) :1894-1906
[4]   DEVELOPMENTAL-CHANGES IN HEPARAN-SULFATE EXPRESSION - INSITU DETECTION WITH MABS [J].
DAVID, G ;
BAI, XM ;
VANDERSCHUEREN, B ;
CASSIMAN, JJ ;
VANDENBERGHE, H .
JOURNAL OF CELL BIOLOGY, 1992, 119 (04) :961-975
[5]   INTEGRAL MEMBRANE HEPARAN-SULFATE PROTEOGLYCANS [J].
DAVID, G .
FASEB JOURNAL, 1993, 7 (11) :1023-1030
[6]   Molecular diversity of heparan sulfate [J].
Esko, JD ;
Lindahl, U .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (02) :169-173
[7]   Daily regulates Dpp morphogen gradient formation in the Drosophila wing [J].
Fujise, M ;
Takeo, S ;
Kamimura, K ;
Matsuo, T ;
Aigaki, T ;
Izumi, S ;
Nakato, H .
DEVELOPMENT, 2003, 130 (08) :1515-1522
[8]   Heparan sulfate: growth control with a restricted sequence menu [J].
Gallagher, JT .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (03) :357-361
[9]  
GREVE H, 1988, J BIOL CHEM, V263, P12886
[10]   Three-dimensional structure of recombinant human osteogenic protein 1: Structural paradigm for the transforming growth factor beta superfamily [J].
Griffith, DL ;
Keck, PC ;
Sampath, TK ;
Rueger, DC ;
Carlson, WD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (02) :878-883